Drug Shortage Report for MYLAN-TADALAFIL
Report ID | 45590 |
Drug Identification Number | 02410648 |
Brand name | MYLAN-TADALAFIL |
Common or Proper name | TADALAFIL |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | TADALAFIL |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 28 BL |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2018-10-29 |
Actual start date | 2018-10-29 |
Estimated end date | 2019-08-22 |
Actual end date | 2019-08-22 |
Shortage status | Resolved |
Updated date | 2019-08-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v58 | 2019-08-23 | French | Compare |
v57 | 2019-08-23 | English | Compare |
v56 | 2019-08-23 | English | Compare |
v55 | 2019-08-15 | French | Compare |
v54 | 2019-08-15 | English | Compare |
v53 | 2019-06-18 | French | Compare |
v52 | 2019-06-18 | English | Compare |
v51 | 2019-04-03 | French | Compare |
v50 | 2019-04-03 | English | Compare |
v49 | 2019-03-28 | French | Compare |
v48 | 2019-03-28 | English | Compare |
v47 | 2019-02-01 | French | Compare |
v46 | 2019-02-01 | English | Compare |
v45 | 2018-11-13 | French | Compare |
v44 | 2018-11-13 | English | Compare |
v43 | 2018-10-30 | English | Compare |
v42 | 2018-10-29 | French | Compare |
v41 | 2018-10-29 | English | Compare |
v40 | 2018-10-27 | English | Compare |
v39 | 2018-10-23 | French | Compare |